Comparison of Anti-mullerian Hormone (AMH) and Hormonal Assays for Phenotypic Classification of Polycystic Ovary Syndrome

Creative Commons License

Ozay A. C., Ozay O. E., GÜLEKLİ B.

GINEKOLOGIA POLSKA, vol.91, no.11, pp.661-667, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 91 Issue: 11
  • Publication Date: 2020
  • Doi Number: 10.5603/gp.a2020.0122
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, Gender Studies Database, MEDLINE, Directory of Open Access Journals
  • Page Numbers: pp.661-667
  • Keywords: polycystic ovary syndrome, phenotype, polycystic ovarian morphology, anti mullerian hormone, hyperandrogenism, LATE REPRODUCTIVE-AGE, INSULIN-RESISTANCE, SERUM AMH, WOMEN, CRITERIA, EXCESS, PCOS, ANDROGEN, OBESITY, LEVEL
  • Dokuz Eylül University Affiliated: Yes


Objectives: The aim is to compare the hormonal status and anti-mullerian hormone (AMH) levels of patients who have different polycystic ovary syndrome (PCOS) phenotypes, polycystic ovarian morphology (PCOM) and healthy women.